Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis
- PMID: 21437211
- PMCID: PMC3061216
- DOI: 10.1155/2010/158514
Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis
Abstract
Our objective was to analyse the relationship between circulating cytokines, autoantibodies, acute phase reactants, and disease activity in DMARDs-naïve rheumatoid arthritis (RA) patients (n = 140). All cytokines were significantly higher in the RA cohort than in healthy controls. Moderate-to-strong positive intercorrelations were observed between Th1/Th2/macrophage/fibroblast-derived cytokines. RF correlated significantly with IL-1β, IL-2, IL-4, IL-10, IL-12, G-CSF, GM-CSF, IFN-γ, and TNF (P < .0001), and aCCP and aMCV with IL-1β, IL-2, IL-4, and IL-10 (P < .0002), while IL-6 correlated best with the acute phase reactants, CRP, and SAA (P < .0001). In patients with a DAS28 score of ≥5.1, IFN-γ, IL-1β, IL-1Ra, TNF, GM-CSF, and VEGF were significantly correlated (P < .04-.001) with high disease activity (HDA). Circulating cytokines in RA reflect a multifaceted increase in immune reactivity encompassing Th1 and Th2 cells, monocytes/macrophages, and synovial fibroblasts, underscored by strong correlations between these cytokines, as well as their relationships with RF, aCCP, and aMCV, with some cytokines showing promise as biomarkers of HDA.
Similar articles
-
HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients.Arthritis Res Ther. 2011;13(5):R160. doi: 10.1186/ar3479. Epub 2011 Oct 6. Arthritis Res Ther. 2011. PMID: 21978430 Free PMC article.
-
A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.J Rheumatol. 2004 Dec;31(12):2336-46. J Rheumatol. 2004. PMID: 15570632
-
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.Clin Exp Immunol. 2015 Nov;182(2):119-31. doi: 10.1111/cei.12677. Epub 2015 Sep 16. Clin Exp Immunol. 2015. PMID: 26149185 Free PMC article.
-
[Cytokines in rheumatoid arthritis].Postepy Hig Med Dosw. 1997;51(6):621-36. Postepy Hig Med Dosw. 1997. PMID: 9481895 Review. Polish.
-
[Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].Biomedica. 2004 Jun;24(2):140-52. Biomedica. 2004. PMID: 15495594 Review. Spanish.
Cited by
-
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.Mediators Inflamm. 2013;2013:183653. doi: 10.1155/2013/183653. Epub 2013 Apr 7. Mediators Inflamm. 2013. PMID: 23690656 Free PMC article.
-
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.BMC Musculoskelet Disord. 2015 May 29;16:130. doi: 10.1186/s12891-015-0587-1. BMC Musculoskelet Disord. 2015. PMID: 26021985 Free PMC article.
-
Rheumatoid arthritis and risk of cardiovascular disease.Cardiovasc J Afr. 2018 Sep/Oct 23;29(5):317-321. doi: 10.5830/CVJA-2018-018. Epub 2018 Mar 27. Cardiovasc J Afr. 2018. PMID: 29583150 Free PMC article. Review.
-
Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.Rheumatol Int. 2014 Feb;34(2):243-53. doi: 10.1007/s00296-013-2895-9. Epub 2013 Nov 13. Rheumatol Int. 2014. PMID: 24221190 Free PMC article.
-
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?BMJ. 2015 Nov 26;351:h5079. doi: 10.1136/bmj.h5079. BMJ. 2015. PMID: 26612523 Free PMC article. Review.
References
-
- Choy EHS, Panayi GS. Cytokine pathways and joint inflamation in rheumatoid arthritis. New England Journal of Medicine. 2001;344(12):907–916. - PubMed
-
- Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–361. - PubMed
-
- Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. The Lancet. 2009;373(9664):659–672. - PubMed
-
- Dolhain RJEM, Van Der Heiden AN, Ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis and Rheumatism. 1996;39(12):1961–1969. - PubMed
-
- Yamada H, Nakashima Y, Okazaki K, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2008;67(9):1299–1304. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous